Perspective trends of topical therapy of patients with psoriasis

par Alexander S. Zhukov, Vladislav R. Khairutdinov, Alexey V. Samtsov
Publié 2021

The new external drug for the treatment of psoriasis based on inhibition of serine proteases

par Alexander S. Zhukov, Evgeny R. Zharun, Vladislav R. Khairutdinov, Alexey V. Samtsov, Mihail Yu. Krasavin, A. V. Garabagiou
Publié 2021

Revisiting the question of cutaneous vasculitis classification

par Alexey V. Samtsov, Vladislav R. Khairutdinov, Evgeny V. Sokolovskiy, Muza M. Kokhan, Irena E. Belousova, Olga Yu. Olisova, Olga V. Grabovskaya, Andrey L. Bakulev, Arfenya E. Karamova
Publié 2021

Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo...

par Luis Puig, Andrey L. Bakulev, Muza M. Kokhan, Alexey V. Samtsov, Vladislav R. Khairutdinov, Maria A. Morozova, Nikita A. Zolkin, Ivan V. Kuryshev, Alexey N. Petrov, Antonina V. Artemeva, Arina V. Zinkina-Orikhan
Publié 2021